L1CAM Predicts Adverse Outcomes in Patients with Endometrial Cancer Undergoing Full Lymphadenectomy and Adjuvant Chemotherapy
- 2 December 2019
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 27 (7) , 2159-2168
Abstract
Background L1 cell adhesion molecule (L1CAM) has been established as an important predictor of poor survival of early-stage endometrial cancer patients. We investigated whether L1CAM remains a...Keywords
This publication has 27 references indexed in Scilit:
- Evaluation of EGFR protein expression by immunohistochemistry using H-score and the magnification rule: Re-analysis of the SATURN studyLung Cancer, 2013
- Overexpression of L1CAM is Associated with Tumor Progression and Prognosis via ERK Signaling in Gastric CancerAnnals of Surgical Oncology, 2013
- L1CAM in Early-Stage Type I Endometrial Cancer: Results of a Large Multicenter EvaluationJNCI: Journal of the National Cancer Institute, 2013
- Integrated genomic characterization of endometrial carcinomaNature, 2013
- L1CAMCell Adhesion & Migration, 2012
- Practice pattern for postoperative management of endometrial cancer in Japan: A survey of the Japanese Gynecologic Oncology GroupGynecologic Oncology, 2009
- Enhanced L1CAM expression on pancreatic tumor endothelium mediates selective tumor cell transmigrationJournal of Molecular Medicine, 2008
- Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: A Japanese Gynecologic Oncology Group studyGynecologic Oncology, 2008
- A validation study of a scoring system to estimate the risk of lymph node metastasis for patients with endometrial cancer for tailoring the indication of lymphadenectomyGynecologic Oncology, 2007
- L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomasThe Lancet, 2003